Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Christian G Chaussy

Christian G Chaussy

University Regensburg, Germany

Title: Transrectal Prostate Cancer Ablation by Robotic High-Intensity Focused Ultrasound (HIFU) at 3 MHz: 20 Years Clinical Experience

Biography

Biography: Christian G Chaussy

Abstract

Currently, on average, prostate cancer is diagnosed 10 years earlier and men live almost 4 years longer than 25 years ago. This means that the therapeutic necessity is more than double the time than it was then. None of the classical therapies is effective enough to cover this time frame as a monotherapy without a significant risk of aggressive recurrence during these years. Therefore, new concepts of multimodal and sequential therapies need to be introduced to cover the longer treatment period effectively to maintain the patient’s quality of life (QOL). One of these new therapeutic modalities is the treatment of prostate cancer with high-intensity focused ultrasound (HIFU). High-intensity focused ultrasound (HIFU) is an emerging, noninvasive, local treatment of prostate cancer with 20 years of clinical experience, during which about 40,000 HIFU treatments have been performed worldwide. This presentation reviews the outcomes of HIFU by Ablatherm (EDAP TMS, Lyon, France), and the evolution currently underway regarding how prostate cancer is diagnosed and treated. This presentation shows the potential of HIFU to be used as local therapy for men with any stage of prostate cancer as an effective tool for salvage therapy and the possibilities for focal therapy of prostate cancer and how these additional therapeutic options can fit within the future armamentarium of a sequential multimodal therapy concept.